Winter Rheumatology Symposium
About the Event
Date:January 25–29, 2026
Location:Snowmass, CO
Credit:CME: TBA, ABIM & ABP MOC: TBA
On Demand:To Be Announced
The Winter Rheumatology Symposium (WRS) provides up-to-date, practical clinical information on the diagnosis and management of patients with rheumatic and immune disorders.
Target Audience
Rheumatologists, members of the interprofessional team, and other healthcare providers who care for patients with rheumatic diseases and those interested or engaged in research in the field of rheumatology.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize and manage complex rheumatic diseases (e.g., rheumatoid arthritis, lupus erythematosus, spondyloarthritis, and osteoporosis)
- Implement evidence-based treatment approaches for autoimmune and inflammatory diseases
- Apply new clinical guidelines to improve patient outcomes
- Utilize collaboration and communication strategies to optimize multidisciplinary patient care
- Consider how to incorporate new technologies (e.g., CAR-T therapy, imaging) into the clinical management of rheumatic disorders
For information about the previous meeting, see the Winter Rheumatology Symposium 2025 section below.
Program Schedule & Syllabi
To Be Announced
Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.
Registration Fees
To Be Announced
Press Registration
The American College of Rheumatology welcomes members of the press to write about research presented at our meetings. Complimentary registration is provided to approved members of the press to allow them to attend sessions on site.
Acknowledgement of Commercial Support
No commercial support was provided for this activity.
CME
ACCME Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.
AMA Designation Statement
The American College of Rheumatology designates this Live Activity for a maximum of (to be announced) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME credit must be claimed by December 31, 2026.
MOC
MOC Recognition Statement: American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to (to be announced) MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.
After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.
MOC points must be claimed by December 31, 2026.
Instructions to Claim CME/MOC Credit
- Login to your My Credit page
- Locate Winter Rheumatology Symposium 2026 and click Claim Credit. Enter the amount of credit commensurate with your participation. (To view or update your credit, select View Credit.)
- After claiming CME, you will be asked if you wish to claim ABIM MOC. If you select Yes, you will be prompted to enter or confirm your MOC Diplomate Number and date of birth. Then you will select areas of key learning and enter a reflective statement.
The deadline to claim CME credit and MOC points for Winter Rheumatology Symposium 2026 is December 31, 2026.
Credit claiming is available after the activity starts.
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patient beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.
WRS 2026 Financial Relationships Disclosures to be announced
The Winter Rheumatology Symposium 2025 was an in-person only event held from January 26–30, 2025, in Snowmass Village, Colorado.
Target Audience
Rheumatologists, members of the interprofessional team, and other healthcare providers who care for patients with rheumatic diseases and those interested or engaged in research in the field of rheumatology.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize and manage complex rheumatic diseases (e.g., rheumatoid arthritis, lupus erythematosus, spondylarthritis, and osteoporosis)
- Implement evidence-based treatment approaches for autoimmune and inflammatory diseases
- Apply new clinical guidelines to improve patient outcomes
- Utilize collaboration and communication strategies to optimize multidisciplinary patient care
- Consider how to incorporate new technologies (e.g., CAR-T therapy, imaging) into the clinical management of rheumatic disorders
Program Schedule & Syllabi
Winter Rheumatology Symposium 2025 Program Schedule
Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.
CME
ACCME Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.
AMA Designation Statement
The American College of Rheumatology designates this Live Activity for a maximum of 21.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME credit must be claimed by December 31, 2025.
MOC
MOC Recognition Statement: American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 21.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.
After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.
MOC points must be claimed by December 31, 2025.
Instructions to Claim CME/MOC Credit
- Login to your My Credit page
- Locate Winter Rheumatology Symposium 2025 and click Claim Credit. Enter the amount of credit commensurate with your participation. (To view or update your credit, select View Credit.)
- After claiming CME, you will be asked if you wish to claim ABIM MOC. If you select Yes, you will be prompted to enter or confirm your MOC Diplomate Number and date of birth. Then you will select areas of key learning and enter a reflective statement.
The deadline to claim CME credit and MOC points for Winter Rheumatology Symposium 2025 is December 31, 2025.
Credit claiming is available after the activity starts.
Financial Relationships Disclosures
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Executive role and/or ownership interest
- Royalties and/or patient beneficiary
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Private investigator
- Expert witness
- Equity interest
- Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.
WRS 2025 Financial Relationships Disclosures
Commercial Support Acknowledgement
No commercial support was provided for this activity.